In general, practices and health systems don’t do a good job of integrating technology into practice, partly because most of the technology they use isn’t well suited to their needs, explained Charles Saunders, MD, CEO of Integra Connect.
In general, practices and health systems don’t do a good job of integrating technology into practice, partly because most of the technology they use isn’t well suited to their needs, explained Charles Saunders, MD, CEO of Integra Connect.
Transcript
How do practices need to use information technology to succeed in the new value-based care environment?
Well, the Oncology Care Model has certain requirements; one of those is the use of an ONC [Office of the National Coordinator]-certified electronic health record. Another one is data-driven quality improvement programs, as well as care navigation, and use of evidence-based care paths and creation and management to an Oncology Care Model care plan. And, so, technology is used for all of those requirements, and I would say the trickiest part of it, however, is curating the data and determining and calculating the performance measures required for the Oncology Care Model.
How well are practices and health systems doing with integrating new technology into practice?
Well, generally, not very well. In most cases, they use an electronic health record (EHR), most of the EHRs out there are not actually suited for the Oncology Care Model. They don’t, oftentimes, capture the data that is necessary to do the calculations, and they don’t actually provide support or enablement for managing care or team-based care management. They’re generally for documenting an episode of care and administering chemotherapy. So, they weren’t really designed for that purpose.
Additionally, the ability to integrate and curate the data is proving to be very difficult, and, in many cases, if not all, some level of manual data curation is necessary.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen